Louis W Sullivan United Therapeutics Corp (UTHR) insider trading activity

Louis W Sullivan is of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 3,200 shares of UTHR, which is worth approximately $1.15 Million. The most recent transaction as insider was on Dec 19, 2024, when has been sold 1,851 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.2K

75.5% 3M change

75.5% 12M change

Total Value Held $1.15 Million

LOUIS W SULLIVAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 19 2024	SELL Bona fide gift	-	1,851 Reduced 36.65%	3,200 Common Stock
Dec 18 2024	SELL Open market or private sale	$9,812,125 $374.38 p/Share	26,209 Reduced 83.84%	5,051 Common Stock
Dec 18 2024	BUY Exercise of conversion of derivative security	$2,631,450 $175.43 p/Share	15,000 Added 32.43%	31,260 Common Stock
May 03 2024	SELL Open market or private sale	$1,332,621 $258.26 p/Share	5,160 Reduced 28.32%	13,060 Common Stock
May 03 2024	BUY Exercise of conversion of derivative security	$617,961 $119.76 p/Share	5,160 Added 22.07%	18,220 Common Stock
Jul 07 2023	BUY Exercise of conversion of derivative security	-	880 Added 6.31%	13,060 Common Stock
Mar 01 2023	SELL Open market or private sale	$171,570 $245.1 p/Share	700 Reduced 5.43%	12,180 Common Stock
Mar 01 2023	BUY Exercise of conversion of derivative security	$92,610 $132.3 p/Share	700 Added 5.15%	12,880 Common Stock
Feb 01 2023	SELL Open market or private sale	$182,931 $261.33 p/Share	700 Reduced 5.43%	12,180 Common Stock
Feb 01 2023	BUY Exercise of conversion of derivative security	$92,610 $132.3 p/Share	700 Added 5.15%	12,880 Common Stock
Jan 03 2023	SELL Open market or private sale	$193,382 $276.26 p/Share	700 Reduced 5.43%	12,180 Common Stock
Jan 03 2023	SELL Exercise of conversion of derivative security	$92,610 $132.3 p/Share	700 Reduced 5.15%	12,880 Common Stock
Dec 01 2022	SELL Open market or private sale	$195,923 $279.89 p/Share	700 Reduced 5.43%	12,180 Common Stock
Dec 01 2022	BUY Exercise of conversion of derivative security	$92,610 $132.3 p/Share	700 Added 5.15%	12,880 Common Stock
Nov 01 2022	SELL Open market or private sale	$161,196 $230.28 p/Share	700 Reduced 5.43%	12,180 Common Stock
Nov 01 2022	BUY Exercise of conversion of derivative security	$92,610 $132.3 p/Share	700 Added 5.15%	12,880 Common Stock
Oct 03 2022	SELL Open market or private sale	$150,208 $211.56 p/Share	710 Reduced 5.51%	12,180 Common Stock
Oct 03 2022	BUY Exercise of conversion of derivative security	$93,933 $132.3 p/Share	710 Added 5.22%	12,890 Common Stock
Sep 02 2022	SELL Open market or private sale	$1,109,562 $225.98 p/Share	4,910 Reduced 28.73%	12,180 Common Stock
Sep 02 2022	BUY Exercise of conversion of derivative security	$499,838 $101.8 p/Share	4,910 Added 22.32%	17,090 Common Stock
Jul 08 2022	BUY Exercise of conversion of derivative security	-	3,230 Added 18.39%	14,330 Common Stock
May 26 2022	SELL Open market or private sale	$1,420,570 $225.13 p/Share	6,310 Reduced 36.24%	11,100 Common Stock
May 26 2022	BUY Exercise of conversion of derivative security	$481,832 $76.36 p/Share	6,310 Added 26.6%	17,410 Common Stock
Jun 26 2021	BUY Exercise of conversion of derivative security	-	1,680 Added 13.15%	11,100 Common Stock
May 11 2021	SELL Sale (or disposition) back to the issuer	$5,829,000 $194.3 p/Share	30,000 Reduced 76.1%	9,420 Common Stock

Also insider at

EBS

Emergent BioSolutions Inc. Healthcare

Director

LWS

Louis W Sullivan

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Value

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR

Account